» Articles » PMID: 35118601

Gom1 Mutant Mice As a Model of Otitis Media

Overview
Date 2022 Feb 4
PMID 35118601
Authors
Affiliations
Soon will be listed here.
Abstract

Otitis media (OM) disease is a common cause of hearing loss that is primarily the result of middle ear infection. At present, our understanding of the mechanisms leading to OM is limited due to the lack of animal models of OM with effusion (OME). Here, we report that the mice with genetic otitis media one (gom1) mutants are prone to OM. gom1 Mice were produced by the N-ethyl-N-nitrosourea (ENU) mutagenesis program as an animal model to study OM. These mice demonstrate many common features of OM, such as middle ear effusion and hearing impairment. We revealed that gom1 mice display various signs of middle ear and inner ear dysfunctions, including elevated thresholds of auditory-evoked brainstem response (ABR) and lack of cochlear microphonic responses. Decreased compliance in tympanometry measurements indicates tympanic membrane and ossicular chain malfunction. We confirmed through histological examinations of middle ear structures that 34/34 (100 %) of the mutant mice suffered from severe OME. While individual ears had different levels of effusion and inflammatory cells in the middle ear cavity, all had thickened middle ear mucosa and submucosa compared to control mice (B6). Moreover, the mutant mice displayed cochlear hair cell loss. These observations also suggested the craniofacial abnormalities in the gom1 mouse model. Together, these results indicate that gom1 mice could be valuable for investigating the genetic contribution to the development of middle ear disease.

Citing Articles

Otitis media: recent advances in otitis media vaccine development and model systems.

Zahid A, Wilson J, Grice I, Peak I Front Microbiol. 2024; 15:1345027.

PMID: 38328427 PMC: 10847372. DOI: 10.3389/fmicb.2024.1345027.


Hearing impairment in murine model of Down syndrome.

Chen G, Li L, McCall A, Ding D, Xing Z, Yu Y Front Genet. 2022; 13:936128.

PMID: 35991545 PMC: 9385999. DOI: 10.3389/fgene.2022.936128.

References
1.
Lin J, Hafren L, Kerschner J, Li J, Brown S, Zheng Q . Panel 3: Genetics and Precision Medicine of Otitis Media. Otolaryngol Head Neck Surg. 2017; 156(4_suppl):S41-S50. PMC: 6211190. DOI: 10.1177/0194599816685559. View

2.
Yang B, Tian C, Zhang Z, Han F, Azem R, Yu H . Sh3pxd2b mice are a model for craniofacial dysmorphology and otitis media. PLoS One. 2011; 6(7):e22622. PMC: 3144925. DOI: 10.1371/journal.pone.0022622. View

3.
Ubell M, Khampang P, Kerschner J . Mucin gene polymorphisms in otitis media patients. Laryngoscope. 2009; 120(1):132-8. PMC: 2919485. DOI: 10.1002/lary.20688. View

4.
Zheng Q, Hardisty-Hughes R, Brown S . Mouse models as a tool to unravel the genetic basis for human otitis media. Brain Res. 2006; 1091(1):9-15. PMC: 2855297. DOI: 10.1016/j.brainres.2006.01.046. View

5.
Han F, Yu H, Tian C, Chen H, Benedict-Alderfer C, Zheng Y . A new mouse mutant of the Cdh23 gene with early-onset hearing loss facilitates evaluation of otoprotection drugs. Pharmacogenomics J. 2010; 12(1):30-44. PMC: 3000876. DOI: 10.1038/tpj.2010.60. View